Yannick Allanore

Also affiliated with Université Paris Cité, Hôpital Cochin, Assistance Publique – Hôpitaux de Paris, Hôpital Saint Joseph, Hôpital Paris Saint-Joseph, Institut Cochin

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Safety and efficacy of abatacept in early diffuse cutaneous systemic sclerosis (ASSET): open-label extension of a phase 2, double-blind randomised trial”.

Safety and efficacy of abatacept in early diffuse cutaneous systemic sclerosis (ASSET): open-label extension of a phase 2, double-blind randomised trial

The Lancet Rheumatology(2020)10.1016/s2665-9913(20)30237-x

N/A

1.1DataRank · unranked

48 citations

Cathie Spino, Richard McLain, Sindhu R. Johnson, Christopher P. Denton, Jerry A. Molitor +27 more

Current and Future Outlook on Disease Modification and Defining Low Disease Activity in Systemic Sclerosis

Arthritis & Rheumatology(2020)10.1002/art.41246

N/A

0DataRank · unranked

38 citations

Marco Matucci‐Cerinic, Daniel E. Furst, Masataka Kuwana, Yannick Allanore, Christopher P. Denton +8 more

OP0250 EFFICACY AND SAFETY OF ROMILKIMAB IN DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS (DCSSC): RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, 24-WEEK, PROOF OF CONCEPT STUDY

Annals of the Rheumatic Diseases(2020)10.1136/annrheumdis-2020-eular.4830

N/A

0DataRank · unranked

6 citations

Peter K. Wung, Christina Soubrane, Corinne Espéret, M. Frederic, Raphaël Bejuit +4 more

OP0251 THE EULAR SYSTEMIC SCLEROSIS IMPACT OF DISEASE (SCLEROID) SCORE – A NEW PATIENT-REPORTED OUTCOME MEASURE FOR PATIENTS WITH SYSTEMIC SCLEROSIS

Annals of the Rheumatic Diseases(2020)10.1136/annrheumdis-2020-eular.5612

N/A

0DataRank · unranked

1 citations

R. Dobrota, K. Fligelstone, A. Roennow, Yannick Allanore, Patrícia Carreira +14 more

Comprehensive analysis of the major histocompatibility complex in systemic sclerosis identifies differential HLA associations by clinical and serological subtypes

Annals of the Rheumatic Diseases(2021)10.1136/annrheumdis-2021-219884

N/A

0DataRank · unranked

42 citations

Martin Kerick, Elena López‐Isac, Shervin Assassi, Lorenzo Beretta, Carmen Pilar Simeón‐Aznar +79 more

OP0170 DECLINE IN FORCED VITAL CAPACITY (FVC) IN PATIENTS WITH SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE (SSC-ILD) WITH AND WITHOUT DYSPNOEA: DATA FROM THE SENSCIS TRIAL

Annals of the Rheumatic Diseases(2021)10.1136/annrheumdis-2021-eular.834

N/A

0DataRank · unranked

0 citations

Michael Kreuter, Anna‐Maria Hoffmann‐Vold, Marlies Wijsenbeek, Vanessa Smith, Dinesh Khanna +7 more

Systemic sclerosis associated interstitial lung disease: a conceptual framework for subclinical, clinical and progressive disease

Lara D. Veeken(2022)10.1093/rheumatology/keac557

N/A

0DataRank · unranked

17 citations

Kevin M. Brown, Ella A. Kazerooni, Donald P Tashkin, Shervin Assassi, Fernando J. Martínez +48 more

Consensus on the assessment of systemic sclerosis–associated primary heart involvement: World Scleroderma Foundation/Heart Failure Association guidance on screening, diagnosis, and follow-up assessment

Journal of Scleroderma and Related Disorders(2023)10.1177/23971983231163413

N/A

0DataRank · unranked

56 citations

Maya H Buch, Aleksandra Djoković, Giacomo De Luca, Raluca B Dumitru, Alessandro Giollo +30 more

ERS/EULAR clinical practice guidelines for connective tissue disease-associated interstitial lung disease

European Respiratory Journal(2025)10.1183/13993003.02533-2024

N/A

0DataRank · unranked

36 citations

Oliver Distler, Ana-Maria Gheorghiu, Catharina C. Moor, Jens Vikse, Nikoleta Bizymi +26 more